검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | omega-3-acid ethyl esters (omega-3-acid ethyl esters) ImmunityBio, Inc.·Merkel Cell Carcinoma ORR null |
|---|---|
Overview Program | omega-3-acid ethyl esters |
Overview Company | ImmunityBio, Inc. |
Overview Modality | CGT |
Overview Target | Merkel Cell Carcinoma |
Overview Indication | Melanoma |
Overview Phase | PHASE_2 |
Overview Status | DISCONTINUED |
MoA Mechanism | of EPA, endogenous formation of EPA-derived anti-inflammatory metabolites is receiving greater attention |
PK/PD Species | Rat |
PK/PD Animal (cat.) | Rat |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Rat |
Toxicology Animal (cat.) | Rat |
Toxicology Major finding | Safety update: omega-3-acid ethyl esters and atrial fibrillation.. Overview of: Medicines and Healthcare products Regulatory Agency. Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000 mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors. Drug Safety Update 2024;17(6):3. Comparison of Omega-3 pol… |
Clinical Result source | ClinicalTrials.gov NCT02370537 |
Clinical Data Tier / Score | A · 13 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 13일 (1일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | omega-3-acid ethyl esters (omega-3-acid ethyl esters) ImmunityBio, Inc.·Merkel Cell Carcinoma ORR null |
|---|---|
Overview Program | omega-3-acid ethyl esters |
Overview Company | ImmunityBio, Inc. |
Overview Modality | CGT |
Overview Target | Merkel Cell Carcinoma |
Overview Indication | Melanoma |
Overview Phase | PHASE_2 |
Overview Status | DISCONTINUED |
MoA Mechanism | of EPA, endogenous formation of EPA-derived anti-inflammatory metabolites is receiving greater attention |
PK/PD Species | Rat |
PK/PD Animal (cat.) | Rat |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Rat |
Toxicology Animal (cat.) | Rat |
Toxicology Major finding | Safety update: omega-3-acid ethyl esters and atrial fibrillation.. Overview of: Medicines and Healthcare products Regulatory Agency. Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000 mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors. Drug Safety Update 2024;17(6):3. Comparison of Omega-3 pol… |
Clinical Result source | ClinicalTrials.gov NCT02370537 |
Clinical Data Tier / Score | A · 13 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 13일 (1일 전) |
추천 비교
추천 비교